Correlation Between Surrozen and Humacyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Surrozen and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surrozen and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Surrozen and Humacyte, you can compare the effects of market volatilities on Surrozen and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surrozen with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surrozen and Humacyte.

Diversification Opportunities for Surrozen and Humacyte

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Surrozen and Humacyte is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and Surrozen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surrozen are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of Surrozen i.e., Surrozen and Humacyte go up and down completely randomly.

Pair Corralation between Surrozen and Humacyte

Given the investment horizon of 90 days Surrozen is expected to generate 0.96 times more return on investment than Humacyte. However, Surrozen is 1.04 times less risky than Humacyte. It trades about 0.02 of its potential returns per unit of risk. Humacyte is currently generating about 0.01 per unit of risk. If you would invest  1,062  in Surrozen on August 31, 2024 and sell it today you would lose (40.00) from holding Surrozen or give up 3.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Surrozen  vs.  Humacyte

 Performance 
       Timeline  
Surrozen 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Surrozen are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Surrozen may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Humacyte 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Humacyte are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Humacyte may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Surrozen and Humacyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Surrozen and Humacyte

The main advantage of trading using opposite Surrozen and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surrozen position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.
The idea behind Surrozen and Humacyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance